This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human Flt-3/Flk-2 Fc Chimera Protein
catalog :
368-ST
quantity :
50 ug
price :
349 USD
citations: 3
Reference |
---|
Donahue R, Wersto R, Allay J, Agricola B, Metzger M, Nienhuis A, et al. High levels of lymphoid expression of enhanced green fluorescent protein in nonhuman primates transplanted with cytokine-mobilized peripheral blood CD34(+) cells. Blood. 2000;95:445-52 pubmed
|
product information
brand :
R&D Systems
master code :
368-ST
SKU :
368-ST-050
product name :
Recombinant Human Flt-3/Flk-2 Fc Chimera Protein
description :
The Recombinant Human Flt-3/Flk-2 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human Flt-3/Flk-2 Fc Chimera Protein has been validated for the following applications: Bioactivity.
target :
Flt-3/Flk-2/CD135
category :
Proteins and Enzymes
unit size :
50 ug
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein.
conjugate :
Unconjugated
purity :
>97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
species :
Human
observed molecular weight :
120 kDa, reducing conditions
theoretical molecular weight :
85.5 kDa (monomer)
gene symbol :
FLT3
details of functionality :
Measured by its ability to inhibit Flt-3 Ligand-induced proliferation of BaF3 mouse pro-B cells transfected with Flt-3. The ED50 for this effect is 0.01-0.03 µg/mL in the presence of rhFlt-3 Ligand at 2 ng/mL.
endotoxin note :
<0.10 EU per 1 µg of the protein by the LAL method.
catalog number base :
368-ST
accessionNumbers :
AAA18947
applications :
Bioactivity
source :
Mouse myeloma cell line, NS0-derived human Flt-3/Flk-2 protein Human Flt-3 (Asn27-Asn541) Accession # AAA18947 DIEGRMD Human IgG1 (Pro100-Lys330) 6-His tag N-terminus C-terminus
2020 USD :
349
2021 USD :
349 USD
alt names :
CD135, CD135 antigen, EC 2.7.10, fetal liver kinase 2, FL cytokine receptor, Flk-2, FLK2, Flt3, FLT-3, FLT3 receptor tyrosine kinase, Fms-like tyrosine kinase 3, fms-related tyrosine kinase 3, growth factor receptor tyrosine kinase type III, Stem cell tyrosine kinase 1, STK-1, STK1EC 2.7.10.1, Tyrosine-protein kinase receptor FLT3
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
questions and comments